Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease metabolic syndrome x
Symptom C0010068|coronary artery disease
Sentences 36
PubMedID- 21743260 Objectives: we investigated the correlation of serum paraoxonase-1 (pon-1) activity with coronary artery disease (cad) in patients with metabolic syndrome (mets).
PubMedID- 24370221 Coronary atherosclerosis lesion features in coronary artery disease patients complicating with metabolic syndrome.
PubMedID- 24055729 The aim of this study was to investigate the association between c-reactive protein (crp) gene polymorphism and metabolic syndrome (mets) with premature coronary artery disease (pcad).
PubMedID- 21986591 A cross-sectional study of the association between heat shock protein 27 antibody titers, pro-oxidant-antioxidant balance and metabolic syndrome in patients with angiographically-defined coronary artery disease.
PubMedID- 24142676 Is metabolic syndrome related with coronary artery disease severity and complexity: an observational study about idf and aha/nhlbi metabolic syndrome definitions.
PubMedID- 20424363 Fasting adiponectin is inversely correlated with metabolic syndrome in patients with coronary artery disease.
PubMedID- 21576834 Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome.
PubMedID- 23007990 11beta-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease.
PubMedID- 22045340 In fact, major depression is associated with increased volumes of visceral fat and high prevalence of the metabolic syndrome, leading to coronary artery disease.
PubMedID- 21498926 Adipose tissue gene expression of adiponectin, tumor necrosis factor-alpha and leptin in metabolic syndrome patients with coronary artery disease.
PubMedID- 21505504 Indeed, others have reported that inflammatory and vascular biomarkers only partially explain the association of metabolic syndrome with coronary artery disease (jacobs et al., 2009).
PubMedID- 20424361 Combination of serum adiponectin level and metabolic syndrome is closely associated with coronary artery disease in japanese subjects with good glycemic control.
PubMedID- 23829426 Elevating triglycerides (tg) level, an essential component of the metabolic syndrome, is independently associated with coronary artery disease (cad) 1.
PubMedID- 24795698 This variant has been associated with metabolic syndrome in patients with coronary artery disease (199).
PubMedID- 25664056 Association of serum chemerin levels with the severity of coronary artery disease in patients with metabolic syndrome.
PubMedID- 21570644 Association of angiotensin ii type 1 receptor gene a1166c polymorphism with the presence of diabetes mellitus and metabolic syndrome in patients with documented coronary artery disease.
PubMedID- 21575630 Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia.
PubMedID- 21718908 Objectives: our purpose was to clarify the clinical utility of identifying metabolic syndrome (mets) in patients with coronary artery disease (cad).
PubMedID- 25935836 Reported that epicardial fat and pericoronary fat are associated with the existence of obesity and metabolic syndrome in patients with coronary artery disease .
PubMedID- 21714290 The inclusion of a short course of metformin in complex therapy of coronary artery disease with metabolic syndrome does not alter the clinical features of disease.
PubMedID- 25729766 To our knowledge, this is the first study to document arterial enlargement in a metabolic syndrome animal model with diffuse coronary artery disease (dcad) in the absence of severe focal stenosis.
PubMedID- 22978689 Cystatin c and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
PubMedID- 20156070 Background: the association of metabolic syndrome with coronary artery disease (cad) has been studied extensively.
PubMedID- 25288499 Effect of low serum total bilirubin levels (coronary artery disease in patients with metabolic syndrome.
PubMedID- 21039444 Background: the metabolic syndrome is associated with coronary artery disease (cad) and with peripheral artery disease (pad), but the underlying mechanisms explaining these associations have not yet been completely clarified.
PubMedID- 21785745 Accumulating evidence has suggested that adipokines play an important role in the development of coronary artery disease in patients with metabolic syndrome .
PubMedID- 24209601 In diabetic patients, after adjusting for possible confounding factors including age, gender, bmi, risk factors for coronary artery disease, duration of diabetes, metabolic syndrome, impaired renal function, and multivessel disease, ga > 18.3% but not hba1c > 7% remained an independent determinant for low collateralization (figure 3).
PubMedID- 24897239 Association of neuropeptide y gene rs16147 polymorphism with metabolic syndrome in patients with documented coronary artery disease.
PubMedID- PMC3382722 14. effects of glp-1 receptor agonist on ca2+ handling of coronary smooth muscle cells from metabolic syndrome ossabaw swine with coronary artery disease.
PubMedID- 20009357 Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease.
PubMedID- 22813403 Prevalence of metabolic syndrome in patients with angiographically proven coronary artery disease presenting to a tertiary care hospital in delhi, india.
PubMedID- 21988056 Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome.
PubMedID- 21134342 Serum slox-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndrome.
PubMedID- 25285291 Association of metabolic syndrome with severity of coronary artery disease.
PubMedID- 23706945 Calcium-phosphorus product concentration is a risk factor of coronary artery disease in metabolic syndrome.
PubMedID- 21847126 There is also potential for wider health benefits; colorectal cancer shares similar risk factors, such as smoking and the metabolic syndrome, with coronary artery disease; thus, aspirin could potentially be beneficial from both an oncological and cardiological perspective (chan et al, 2007).

Page: 1